Home > Healthcare > Medical Devices > Diagnostic Devices > Point-of-Care Glucose Testing Market

Point-of-Care Glucose Testing Market Trends

  • Report ID: GMI11241
  • Published Date: Sep 2024
  • Report Format: PDF

Point-of-Care Glucose Testing Market Trends

Recent advancements in point-of-care (POC) glucose testing have significantly enhanced the accuracy, convenience, and overall management of diabetes. Innovations, ranging from integration with continuous glucose monitoring systems to the development of advanced sensor technologies, are transforming how glucose levels are monitored and managed.
 

  • Modern point-of-care glucose meters are increasingly integrating with continuous glucose monitoring systems. This allows for real-time glucose tracking and trend analysis, enhancing diabetes management and providing more comprehensive data to both patients and healthcare providers.
     
  • For instance, in February 2023, Dexcom launched its next-generation Dexcom G7 CGM System, featuring a sensor 60% smaller than its predecessor (G6). The G7 provides real-time glucose data directly to smartphones or smartwatches, eliminating the need for fingerstick tests. It is designed for individuals with type 1, type 2, or gestational diabetes.
     
  • Many point-of-care glucose meters now include Bluetooth or Wi-Fi capabilities for seamless data transfer to smartphones, tablets, or cloud platforms. This enhances data management and enables remote monitoring by healthcare professionals. For example, Abbott's FreeStyle Libre 3 offers real-time glucose readings through a compact sensor and integrates with the FreeStyle LibreLink app for continuous tracking and data sharing.
     
  • Additionally, advancements in biosensor technologies, including non-invasive methods like infrared spectroscopy and radio waves, are being developed to further enhance accuracy and reliability. These innovations aim to eliminate the need for traditional blood samples and advance the overall effectiveness of glucose monitoring, thus propelling market growth.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The point-of-care glucose testing market was valued at USD 3.4 billion in 2023 and will witness a 4.7% CAGR between 2024 and 2032 driven by the rising incidence of diabetes.

The test strips segment in the point-of-care glucose testing industry will attain USD 2.3 billion by 2032, due to their high accuracy and precision in glucose measurement.

U.S. point-of-care glucose testing market is expected to surpass USD 1.9 billion by 2032, owing to the highest diabetes prevalence rates, along with a well-established healthcare infrastructure that supports the widespread use of advanced medical technologies.

Abbott Laboratories, ARKRAY, Inc., ACON Laboratories, Inc., B. Braun Melsungen AG, and Dexcom, Inc., among others.

Point-of-Care Glucose Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 161
  • Countries covered: 23
  • Pages: 85
 Download Free Sample